Bladder cancer diagnosis and identification of clinically significant disease by combined urinary detection of Mcm5 and nuclear matrix protein 22.

by John D Kelly, Tim J Dudderidge, Alex Wollenschlaeger, Odu Okoturo, Keith Burling, Fiona Tulloch, Ian Halsall, Teresa Prevost, Andrew Toby Prevost, Joana C Vasconcelos, Wendy Robson, Hing Y Leung, Nikhil Vasdev, Robert S Pickard, Gareth H Williams, Kai Stoeber
Published 2012-01-01

Which prostate cancers are overlooked by mpMRI? An analysis from PROMIS

by J. Norris, L. Carmona Echeverria, S.R.J. Bott, L. Brown, N. Burns-Cox, T.J. Dudderidge, A. El-Shater Bosaily, E. Frangou, A. Freeman, M. Ghei, A. Henderson, R.G. Hindley, R.S. Kaplan, A. Kirkham, R. Oldroyd, C. Parker, R. Persad, S. Punwani, D.J. Rosario, I.S. Shergill, V. Stavrinides, M. Winkler, H.C. Whitaker, H.U. Ahmed, M. Emberton
Published 2020-07-01